1. Ilan, Y (2016) Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance. American Journal of Physiology-Gastrointestinal and Liver Physiology 310: G1102–G1117.
Google Scholar | Crossref | Medline2. Hannun, YA, Obeid, LM (2018) Sphingolipids and their metabolism in physiology and disease. Nature Reviews Molecular Cell Biology 19: 175–191.
Google Scholar | Crossref | Medline3. Quinville, BM, Deschenes, NM, Ryckman, AE, et al. (2021) A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis. International journal of molecular sciences 22: 22.
Google Scholar | Crossref4. Ventura, AE, Mestre, B, Silva, LC (2019) Ceramide Domains in Health and Disease: A Biophysical Perspective. Bioactive Ceramides in Health and Disease 1159: 79–108.
Google Scholar | Crossref5. Sukocheva, OA, Furuya, H, Ng, ML, et al. (2020) Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. Pharmacology and Therapeutics 207: 107464.
Google Scholar | Crossref | Medline6. Zheng, X, Li, W, Ren, L, et al (2019) The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy. Pharmacology and Therapeutics 195: 85–99.
Google Scholar | Crossref | Medline7. Snider, AJ (2013) Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease. International journal of clinical rheumatology 8.
Google Scholar | Crossref | Medline8. Nagahashi, M, Abe, M, Sakimura, K, et al. (2018) The role of sphingosine‐1‐phosphate in inflammation and cancer progression. Cancer Science 109: 3671–3678.
Google Scholar | Crossref | Medline9. Watson, L, Tullus, K, Marks, SD, et al. (2012) Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus. Journal of Clinical Immunology 32: 1019–1025.
Google Scholar | Crossref | Medline10. Mike, EV, Makinde, HM, Der, E, et al. (2018) Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling. Frontiers in Immunology 9: 2189.
Google Scholar | Crossref | Medline11. Mihanfar, A, Nejabati, HR, Fattahi, A, et al. (2019) The role of sphingosine 1 phosphate in coronary artery disease and ischemia reperfusion injury. Journal of Cellular Physiology 234: 2083–2094.
Google Scholar | Crossref | Medline12. Wang, E, He, X, Zeng, M (2019) The Role of S1P and the Related Signaling Pathway in the Development of Tissue Fibrosis. Frontiers in pharmacology 9: 1504.
Google Scholar | Crossref | Medline13. Ishay, Y, Nachman, D, Khoury, T, et al. (2020) The role of the sphingolipid pathway in liver fibrosis: an emerging new potential target for novel therapies. American Journal of Physiology-Cell Physiology 318: C1055–C1064.
Google Scholar | Crossref | Medline14. Nagahashi, M, Yamada, A, Katsuta, E, et al. (2018) Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis. Cancer Research 78: 1713–1725.
Google Scholar | Crossref | Medline15. Wang, P, Yuan, Y, Lin, W, et al. (2019) Roles of sphingosine-1-phosphate signaling in cancer. Cancer Cell International 19: 295.
Google Scholar | Crossref | Medline16. Kleuser, B (2018) Divergent Role of Sphingosine 1-Phosphate in Liver Health and Disease. International journal of molecular sciences 19: 722.
Google Scholar | Crossref17. Rohrbach, T, Maceyka, M, Spiegel, S (2017) Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology. Critical reviews in biochemistry and molecular biology 52: 543–553.
Google Scholar | Crossref | Medline18. Tian, T, Tian, W, Yang, F, et al. (2016) Sphingosine kinase 1 inhibition improves lipopolysaccharide/D‐galactosamine‐induced acute liver failure by inhibiting mitogen‐activated protein kinases pathway. United European Gastroenterology Journal 4: 677–685.
Google Scholar | SAGE Journals | ISI19. Lei, Y-C, Yang, LL, Li, W, et al. (2015) Inhibition of sphingosine kinase 1 ameliorates acute liver failure by reducing high-mobility group box 1 cytoplasmic translocation in liver cells. World Journal of Gastroenterology 21: 13055–13063.
Google Scholar | Crossref | Medline | ISI20. Wang, H-X, Liu, M, Weng, SY, et al. (2012) Immune mechanisms of Concanavalin A model of autoimmune hepatitis. World Journal of Gastroenterology 18: 119–125.
Google Scholar | Crossref | Medline | ISI21. Kaneko, T, Murakami, T, Kawana, H, et al. (2006) Sphingosine-1-phosphate receptor agonists suppress concanavalin A-induced hepatic injury in mice. Biochemical and Biophysical Research Communications 345: 85–92.
Google Scholar | Crossref | Medline22. Yuza, K, Nakajima, M, Nagahashi, M, et al. (2018) Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression. Journal of Surgical Research 232: 186–194.
Google Scholar | Crossref | Medline23. Tonelli, F, Alossaimi, M, Natarajan, V, et al (2013) The roles of sphingosine kinase 1 and 2 in regulating the metabolome and survival of prostate cancer cells. Biomolecules 3: 316–333.
Google Scholar | Crossref | Medline24. Trop, S, Samsonov, D, Gotsman, I, et al. (1999) Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model. Hepatology 29: 746–755.
Google Scholar | Crossref | Medline25. Falcone, M, Facciotti, F, Ghidoli, N, et al. (2004) Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. The Journal of Immunology 172: 5908–5916.
Google Scholar | Crossref | Medline26. Avni, D, Harikumar, KB, Sanyal, AJ, et al. (2021) Deletion or inhibition of SphK1 mitigates fulminant hepatic failure by suppressing TNFα-dependent inflammation and apoptosis. FASEB journal : Official Publication of the Federation of American Societies for Experimental Biology 35: e21415.
Google Scholar | Crossref | Medline27. Qiang, G-H, Wang, Z-X, Ji, A-L, et al. (2019) Sphingosine kinase 1 knockout alleviates hepatic ischemia/reperfusion injury by attenuating inflammation and oxidative stress in mice. Hepatobiliary & Pancreatic Diseases International 18: 255–265.
Google Scholar | Crossref | Medline28. Ilan, Y (2019) β-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems. Frontiers in Immunology 10: 1143.
Google Scholar | Crossref | Medline29. Espaillat, MP, Kew, RR, Obeid, LM (2017) Sphingolipids in neutrophil function and inflammatory responses: mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis. Advances in biological regulation 63: 140–155.
Google Scholar | Crossref | Medline30. Hollmann, C, Wiese, T, Dennstädt, F, et al. (2019) Translational Approaches Targeting Ceramide Generation From Sphingomyelin in T Cells to Modulate Immunity in Humans. Frontiers in Immunology 10: 2363.
Google Scholar | Crossref | Medline31. Maceyka, M, Spiegel, S (2014) Sphingolipid metabolites in inflammatory disease. Nature 510: 58–67.
Google Scholar | Crossref | Medline | ISI32. Tiper, IV, East, JE, Subrahmanyam, PB, et al. (2016) Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection. Pathogens and disease 74: ftw063.
Google Scholar | Crossref | Medline33. Fitzpatrick, LR, Green, C, Frauenhoffer, EE, et al. (2011) Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase. Inflammopharmacology 19: 75–87.
Google Scholar | Crossref | Medline34. Nishiuma, T, Nishimura, Y, Okada, T, et al. (2008) Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. American Journal of Physiology-Lung Cellular and Molecular Physiology 294: L1085–L1093.
Google Scholar | Crossref | Medline | ISI35. Varela, ARP, Couto, AS, Fedorov, A, et al. (2016) Glucosylceramide Reorganizes Cholesterol-Containing Domains in a Fluid Phospholipid Membrane. Biophysical journal 110: 612–622.
Google Scholar | Crossref | Medline36. Zigmond, E, Preston, S, Pappo, O, et al. (2007) Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders. Gut 56: 82–89.
Google Scholar | Crossref | Medline37. Lalazar, G, Zigmond, E, Weksler-Zangen, S, et al. (2017) Oral Administration of β-Glucosylceramide for the Treatment of Insulin Resistance and Nonalcoholic Steatohepatitis: Results of a Double-Blind, Placebo-Controlled Trial. Journal of Medicinal Food 20: 458–464.
Google Scholar | Crossref | Medline38. Rivera, J, Proia, RL, Olivera, A (2008) The alliance of sphingosine-1-phosphate and its receptors in immunity. Nature Reviews Immunology 8: 753–763.
Google Scholar | Crossref | Medline | ISI39. Sassoli, C, Pierucci, F, Zecchi-Orlandini, S, et al. (2019) Sphingosine 1-Phosphate (S1P)/ S1P Receptor Signaling and Mechanotransduction: Implications for Intrinsic Tissue Repair/Regeneration. International journal of molecular sciences 20: 5545.
Google Scholar | Crossref40. Gatfield, J, Monnier, L, Studer, R, et al. (2014) Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling. Cellular Signalling 26: 1576–1588.
Google Scholar | Crossref | Medline41. Huwiler, A, Zangemeister-Wittke, U (2018) The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives. Pharmacology and Therapeutics 185: 34–49.
Google Scholar | Crossref | Medline42. Zhong, M, Wu, W, Wang, Y, et al. (2020) Inhibition of Sphingosine Kinase 1 Attenuates Sepsis-induced Microvascular Leakage via Inhibiting Macrophage NLRP3 Inflammasome Activation in Mice. Anesthesiology 132: 1503–1515.
Google Scholar | Crossref | Medline43. Pyne, S, Edwards, J, Ohotski, J, et al. (2012) Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers. Frontiers in oncology 2: 168.
Google Scholar | Crossref | Medline44. Ilan, Y (2019) Immune rebalancing by oral immunotherapy: A novel method for getting the immune system back on track. Journal of Leukocyte Biology 105: 463–472.
Google Scholar | Crossref | Medline45. Ilan, Y, Ohana, M, Pappo, O, et al. (2007) Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity. Transplantation 83: 458–467.
Google Scholar | Crossref | Medline46. Snider, AJ, Ruiz, P, Obeid, LM, et al. (2013) Inhibition of Sphingosine Kinase-2 in a Murine Model of Lupus Nephritis. PLOS ONE 8: e53521.
Google Scholar | Crossref | Medline47. Mohammed, S, Vineetha, NS, James, S, et al. (2019) Examination of the role of sphingosine kinase 2 in a murine model of systemic lupus erythematosus. The FASEB Journal 33: 7061–7071.
Google Scholar | Crossref | Medline48. Neubauer, HA, Pitson, SM (2013) Roles, regulation and inhibitors of sphingosine kinase 2. FEBS Journal 280: 5317–5336.
Google Scholar | Crossref49. Erhardt, A, Biburger, M, Papadopoulos, T, et al. (2007) IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 45: 475–485.